Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.
Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expre...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2997799?pdf=render |
id |
doaj-b2109f69e19940a980124f78779c1f2a |
---|---|
record_format |
Article |
spelling |
doaj-b2109f69e19940a980124f78779c1f2a2020-11-25T01:18:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-12-01512e1525310.1371/journal.pone.0015253Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets.Aaron ErdelyDiane Kepka-LenhartRebecca Salmen-MunizRebecca ChapmanTracy HuldermanMichael KashonPetia P SimeonovaSidney M MorrisIncreased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease.http://europepmc.org/articles/PMC2997799?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Aaron Erdely Diane Kepka-Lenhart Rebecca Salmen-Muniz Rebecca Chapman Tracy Hulderman Michael Kashon Petia P Simeonova Sidney M Morris |
spellingShingle |
Aaron Erdely Diane Kepka-Lenhart Rebecca Salmen-Muniz Rebecca Chapman Tracy Hulderman Michael Kashon Petia P Simeonova Sidney M Morris Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. PLoS ONE |
author_facet |
Aaron Erdely Diane Kepka-Lenhart Rebecca Salmen-Muniz Rebecca Chapman Tracy Hulderman Michael Kashon Petia P Simeonova Sidney M Morris |
author_sort |
Aaron Erdely |
title |
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. |
title_short |
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. |
title_full |
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. |
title_fullStr |
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. |
title_full_unstemmed |
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. |
title_sort |
arginase activities and global arginine bioavailability in wild-type and apoe-deficient mice: responses to high fat and high cholesterol diets. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-12-01 |
description |
Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease. |
url |
http://europepmc.org/articles/PMC2997799?pdf=render |
work_keys_str_mv |
AT aaronerdely arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT dianekepkalenhart arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT rebeccasalmenmuniz arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT rebeccachapman arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT tracyhulderman arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT michaelkashon arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT petiapsimeonova arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets AT sidneymmorris arginaseactivitiesandglobalargininebioavailabilityinwildtypeandapoedeficientmiceresponsestohighfatandhighcholesteroldiets |
_version_ |
1725140370800508928 |